Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.
- DOI
- 10.3390/ijerph19127417
- Published
- 2022 Jun 16
- Container
- International journal of environmental research and public health
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijerph19127417,
title = {Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.},
author = {Murayama A and Kamamoto S and Saito H and Yamada K and Bhandari D and Shoji I and Mamada H and Kawashima M and Yamashita E and Kusumi E and Sawano T and Sapkota B and Tanimoto T and Ozaki A},
year = {2022},
journal = {International journal of environmental research and public health},
doi = {10.3390/ijerph19127417},
url = {https://doi.org/10.3390/ijerph19127417}
}RIS
TY - JOUR TI - Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019. AU - Murayama A AU - Kamamoto S AU - Saito H AU - Yamada K AU - Bhandari D AU - Shoji I AU - Mamada H AU - Kawashima M AU - Yamashita E AU - Kusumi E AU - Sawano T AU - Sapkota B AU - Tanimoto T AU - Ozaki A PY - 2022 JO - International journal of environmental research and public health DO - 10.3390/ijerph19127417 UR - https://doi.org/10.3390/ijerph19127417 ER -
APA
A, M., S, K., H, S., K, Y., D, B., I, S., H, M., M, K., E, Y., E, K., T, S., B, S., T, T., & A, O. (2022). Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.. International journal of environmental research and public health. https://doi.org/10.3390/ijerph19127417
Source records
- pubmed · retrieved 2026-09-26T13:29:37.675Z
- europe-pmc · retrieved 2026-09-26T13:29:37.677Z